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A B S T R A C T
The global market for herbal medicine is growing steadily. The usage of herbal medicine is particularly
common in many parts of Africa; the World Health Organization estimates that approximately 80% of
Africans rely on traditional African medicines (TAMs) for treating various diseases. TAMs hold promise in
preventive treatment, early disease intervention and personalized medicine. However, clinical
integration of TAMs is restricted due to limited information concerning their characterization. Presently,
many studies on TAMs utilize a reductionist approach, making it extremely difﬁcult to understand the
holistic modifying effects that these therapeutic agents may have on biological systems. Fortunately,
emerging technologies such as metabolomics platforms adopt a ‘top-down’ strategy that permits a
holistic evaluation of the components, metabolic pathways and biomarkers modiﬁed by TAMs, which can
aid in addressing common concerns over safety and toxicity, while also ensuring that quality control
standards are met. Metabolomics approaches may also be beneﬁcial for advancing our understanding of
the efﬁcacy and mechanism of action of TAMs, and may contribute to the advancement of research and
drug discovery, early diagnosis, preventive treatment and TAMs-driven personalized medicine in Africa.
This review also considers the main challenges that may hinder the adoption and integration of
metabolomics approaches in research on TAMs in Africa and suggests possible solutions.
ã 2016 The Authors. Published by Elsevier Ltd on behalf of Phytochemical Society of Europe. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Several plant species possess a variety of chemical constituents
that are traditionally exploited in the management of diseases
(Muthaura et al., 2015). Traditional medicines hold promise in
early disease intervention, combination therapy and personalized
medicine (Wang et al., 2011a,b). The global market for traditional
medicine is projected to reach US $ 115 billion by 2020, with the
sale of Chinese herbal medicine alone reaching US $ 83 billion in
2008 (Robinson and Zhang, 2011; WHO, 2013). The use of
traditional medicine in disease management is particularly high
in African communities. The World Health Organization (WHO)
reported that about 80% of Africans use traditional medicine for
primary health care (WHO, 2003) and that the ratio of traditional
healers to population on the continent is 1:500, while the ratio of
doctors to population is 1:40,000 (WHO, 2013). This reliance on
traditional medicines is reportedly high among rural populations;
this trend may have started due to a general lack of access to public
healthcare facilities in such areas (Mothupi, 2014). In Ghana,
Nigeria, Zambia and Mali, traditional African medicines (TAMs)
constitute the ﬁrst line of treatment for about 60% of children with
high fever (resulting from malaria) that are treated at home (WHO,
2013). Moreover, about 75% of HIV/AIDS patients in South Africa
use TAMs (WHO, 2003). The use of TAMs in these areas may be
inﬂuenced by the general ease of access, perceived efﬁcacy, and
beliefs about their safety over generations (Langlois-Klassen et al.,
2007). However, the use of TAM is similarly popular in urban areas
where relatively good access to mainstream healthcare facilities
exists (Bamidele et al., 2009; Njoroge and Kibunga, 2007),
indicating a high consumer base for these products. Apart from
using TAMs as the main treatment paradigmfor various diseases,
consumers also use them to complement other medicines or as
dietary supplements to improve their general health.
Although TAMs are heavily relied on, their insufﬁcient
characterization at the molecular level limits their clinical use.
The reporting and analysis of these traditional medicines, their
interactions with other drugs, safety, side effects, tolerance,
hypersensitivity, reactions due to overdose and toxic effects also
need to be investigated and reported (Cordell, 2014). Moreover, the
components, manufacturing standards, and the addition of
synthetic drugs of low quality are of great concern, especially as
some studies have reported a lack of quality in the production,
trade and prescription of some traditional medicines (Abew et al.,
2014; Cordell, 2014). However, identifying the components of
traditional medicines in general and their formulation is quite
challenging and time consuming due to the complexity and the
large number of detectable metabolites (Guo et al., 2015). The
methodologies used in traditional medicine research follow the
path of reductive analysis, thus contributing to the difﬁculty in
characterizing them, especially with regards to their holistic
modifying effects on biological components (Wang et al., 2011a,b).
Metabolomics offer an opportunity to develop a systematic/
holistic analysis of the components, biomarkers and metabolic
pathways modiﬁed by traditional medicines (Cao et al., 2015),
which can clarify the mechanism of action of TAMs. Metabolomics
(focused on the study of the set of metabolites present in a cell or
tissue) or metabonomics (related to the investigation of the effect
of human nutrition, drugs and diseases) adopt a ‘top-down’
strategy and reﬂects the function of organisms from terminalsymptoms of metabolic networks and provides an holistic view of
the alterations in metabolic pathways caused by interventions (Cao
et al., 2015; Wang et al., 2011a,b). In recent times, metabolomics
has increasingly been used in the study of Chinese and Western
medicines (Cao et al., 2015). Based on this, we discuss how
metabolomics approaches could be employed to advance research
and clinical use of TAMs.
2. Research and therapeutic use of TAMs
Over the years, TAMs have been used in the management of
several diseases, ranging from neurological disorders and inﬂam-
matory conditions to various forms of cancer (Akindele et al.,
2015). While some of these medicines are used in the management
of speciﬁc diseases, others seem to be potent against several
diseases and may be used alone or in combination with other
agents. A summary of the therapeutic importance of the commonly
investigated TAMs is detailed below. Sanseveiria liberica Gerome
and Labroy (family: dracaenaceae), which is commonly called
“mother-in-law tongue” or “African bowstring” is an important
perennial plant with thick woody rhizomes distributed widely in
the tropical, subtropical and temperate zones (Chinasa et al., 2011).
Extract preparations of this plant are used in the treatment of
various diseases including inﬂammation (leaf juice), ear and eye
infections, headache, fever, cold (fume from burning leaves must
be inhaled), epilepsy, measles, venereal diseases, convulsion and
diarrhea (Adeyemi et al., 2007; Bero et al., 2009; Chinasa et al.,
2011). Recently, hydroethanolic extract of S. liberica has also been
shown to exhibit signiﬁcant dose-dependent antitumor activity in
in vivo models of sarcoma and lymphoid leukemia (Akindele et al.,
2015). In South Africa, Burkea africana Hook. (family: legumino-
sae), Leucaenea lucocephala (Lam) de Wit (family: fabaceae), and
Lippia javanica (Burm. f.) Spreng. (family: verbenaceae) have been
shown to possess anti-inﬂammatory, anticholinesterase and
antioxidant activities (Dzoyem and Eloff, 2015). Also, acetone
extracts of Senna italica Mill. subsp. arachoides (Burch.) Lock
(family: fabaceae), Catharanthus roseus (L.) G.Don (family: apoc-
ynaceae), Solanum panduriforme, E.Mey. (family: solanaceae), and
Gomphocarpus fruticossus (L.) Aiton f. subsp. Fruticosus (family:
apocynaceae) have also shown potency (>70%) against Neisseria
gonorrhea (Mulaudzi et al., 2015). In addition, Ricinus communis
(family: euphorbiaceae) and Zehneria scabra (Linn. f.) Sond.
(family: cucurbitacae), in Ethiopia, have been shown to have
bactericidal activity against Escheria coli and methicillin resistant
Staphylococcus aureus (Abew et al., 2014). Dodonaea angustifolia L. f.
(family: sapindaceae) and Rumex nepalensis Spreng. (family:
Polygonaceae) also demonstrated signiﬁcant combinatory anti-
proliferative/antioxidant effect, while Verbascum sinaiticum Benth.
(family: scrophulariaceae) showed selective antiproliferative
potential (Tauchen et al., 2015). Remarkably, a recent study has
shown that acetate extracts of date palm pollen collected from
Tunisian cultivars of Kerkennah and Tozeur showed effect against
Listeria monocytogenes and Staphylococcus aureus respectively,
suggesting that date palm pollen may be a potential inhibitor of
some food-poisoning microbes (Daoud et al., n.d.). While these
studies give an indication of a growing interest in TAM use, our
current understanding of the mechanism of action, safety, and
toxicity of these traditional medicines is still limited. Applying
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drug discovery and disease management.
3. Untargeted metabolomics for a comprehensive evaluation of
TAMs
The rising popularity along with the increased toxicity of herbal
products has resulted in a growing need for a deeper knowledge on
these products. To improve our knowledge of these herbal
products, metabolomics approaches may be crucial. The two main
approaches in metabolomics are the targeted (biased) and
untargeted (unbiased) metabolite proﬁling. While the targeted
approach targets a speciﬁc subset of metabolites in a sample, the
untargeted approach examines the complete metabolome (Com-
misso et al., 2013). Untargeted metabolomics has become a useful
approach for carrying out comprehensive qualitative and quanti-
tative evaluation of herbal products (Chauthe et al., 2012;
Commisso et al., 2013; Heyman and Meyer, 2012). Analytical
techniques employed in metabolomic studies include liquid
chromatography-mass spectroscopy (LC–MS), gas
chromatography–mass spectroscopy, capillary electrophoresis-
mass spectroscopy, thin layer chromatography, Fourier trans-
formed infrared spectroscopy and nuclear magnetic resonance
(NMR) spectroscopy. Amongst these, the most popular analytical
methods are those based on MS and NMR spectroscopy. Recent
progress made in analytical chemistry regarding the detection and
characterization of small molecule compounds such as MS and
high-ﬁeld NMR, along with modern multivariate statistics have
resulted in highly efﬁcient systems for comprehensive evaluation
of metabolite data generated in metabolomic studies (Lindon et al.,
2007). This review focuses more on the LC–MS and NMR
techniques due to their rapid and robust characteristics, which
are essential for evaluating TAMs.
3.1. Workﬂow of untargeted (LC–MS and NMR-based) metabolomics
experiments
A ﬂow chart of a typical NMR and LC–MS untargeted
metabolomics experiment is shown in Fig. 1. The main stages
include sample collection and preparation (extraction), data
acquisition, data processing and analysis, and metabolite identiﬁ-
cation, which may allow biological interpretation. The sample
collection and extraction stage is critical, as the collection of plant
material needs to take into account several factors that can
inﬂuence sample integrity including collection time, season,
weather, soil, etc. (Heyman and Meyer, 2012). In addition, the
extraction method and solvents used can inﬂuence the metabolite
yield and the range of metabolites extracted. While a single solvent
system has been used in extracting metabolites in some studies,
using a combination of solvents (e.g. D2O and CD3OD or KH2PO4Samp le coll econ and  
preparaon
Data acqu ision
Data process ing
Data analysis and  
interpretaon
Metaboli te idenﬁcaon
Fig. 1. Typical untargeted metabolomics workﬂow.combinations for NMR analysis) is preferred as it yields a much
more diverse metabolites from plant samples (Kim et al., 2005;
Van Der Kooy et al., 2009).
Several studies have recently considered the major data
processing challenges that may arise from untargeted metabolo-
mics, and ways of overcoming them (Boccard et al., 2010; Eliasson
et al., 2012; Gil et al., 2016; Nicholson and Lindon, 2008). Data
processing tools such as ACD Labs (http://www.acdlabs.com/),
MetaboAnalyst (http://www.metaboanalyst.ca/) and SIMCA
(http://umetrics.com/products/simca) for NMR and XCMS
(https://metlin.scripps.edu/xcms/), MZmine (http://mzmine.sour-
ceforge.net/), and MetAlign (http://www.metalign.wur.nl) for LC–
MS, have been designed to extract useful information from batches
of crude spectroscopic and chromatographic data, permitting the
rapid processing of multiple variables or data points, making
untargeted metabolomics quite useful (Commisso et al., 2013).
3.2. Data analysis and metabolite identiﬁcation in untargeted
metabolomics
The data acquired using LC–MS or NMR may be analyzed using
one of the two major routes, based on the aim of the study (Boccard
et al., 2010; Heyman and Meyer, 2012). In targeted metabolomics
where a small number of speciﬁc metabolites are proﬁled,
quantitative methods may be used to analyze the metabolites of
interest and statistical signiﬁcance tested via univariate and other
classical statistical methods. However, in untargeted metabolo-
mics, which aims to provide a more global/holistic picture of the
investigated sample, a large number of known and unknown
metabolites are obtained, which are all quantiﬁed and analyzed
simultaneously (Schultz et al., 2013). Statistical signiﬁcance of such
large data sets from untargeted metabolomics are tested using
multivariate statistical methods, as the use of univariate and other
classical statistical methods becomes less feasible. While both
targeted and untargeted metabolomics approaches detect patterns
in metabolites, only untargeted metabolomics permits the
detection of synergistic effects between variables, which cannot
be detected at the individual level. Commonly used multivariate
statistical techniques are based on projection methods, which
combine examined variables into the so-called latent variables for
solving the problem being investigated (Westerhuis et al., 2010).
The unsupervised technique, principal component analysis (PCA)
is used for exploratory data analysis and it summarizes the
information in a given data set using a small number of orthogonal
latent variables. However, the supervised techniques such as
projection to latent structures discriminant analysis (PLS-DA) or
orthogonal projection to latent structures discriminant analysis
(OPLS-DA) are preferred to extract hidden information that
classiﬁes and explain system behavior (Westerhuis et al., 2010).
Metabolite identiﬁcation represent another signiﬁcant chal-
lenge in untargeted metabolomics, especially as plants often
transform secondary metabolites via glycosylation and esteriﬁca-
tion to produce species dependent metabolic proﬁles. While these
diverse molecules could be beneﬁcial in terms of their pharmaco-
logical properties, they are rather difﬁcult to identify with accuracy
(Commisso et al., 2013). However, several metabolite feature
databases have been assembled including MS2T (http://prime.psc.
riken.jp/lcms/ms2tview/ms2tview.html), METLIN (https://metlin.
scripps.edu/), HMDB (http://www.hmdb.ca/;), Birmingham Me-
tabolite Library (http://www.bml-nmr.org/;), Campus Chemical
Instrument Center (http://www.bml-nmr.org/;), and MASSBANK
(http://www.massbank.jp/index.html) (Bingol et al., 2014; Horai
et al., 2010; Matsuda et al., 2009). NMR parameters can be
particularly sensitive to temperature, concentration, pH, and ionic
conditions (Weljie et al., 2006), therefore for a better metabolite
identiﬁcation, the spectra of samples being examined may need to
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databases. For a set of similar samples in a study, it may be
necessary for identiﬁed metabolites to be veriﬁed using a series of
multidimensional NMR experiments, which maps the carbon
skeleton. Such multidimensional NMR experiments may include
HSQC, HMQC, HMBC, TOCSY or a combination of either HSQC or
HMQC and TOCSY (HSQC/HMQC-TOCSY) (Carvalho et al., 1998;
Powers, 2009). In addition, functional groups could be determined
by making use of derivatizing reagents (chemically selective
probes), which target speciﬁc functional groups. When an enriched
atom (15N or 13C) is introduced at a speciﬁc position in the
chemically selective probe, the isotope-editing feature of NMR
could be utilized to detect only those metabolites with the
functional groups of interest (Bousamra et al., 2014). Chemically
selective probes have, for example, been designed to select for
functional groups such as ketones and aldehydes (Bousamra et al.,
2014), carboxylates and thiols (Gori et al., 2014).
3.3. Challenges associated with untargeted metabolomics and
emerging measures to overcome them
Untargeted metabolomics approaches such as LC–MS and NMR
allowfor a rapid, high-throughput and automated assessment of
crude extracts and the quantitative detection of several different
metabolites (Kim et al., 2010), while also providing structural
information including stereochemical details (Seger and Sturm,
2007). Over the last few decades, these metabolomics approaches
have been used to successfully determine the small molecule basis
of several biological processes such as those linked with disease
pathogenesis (Wang et al., 2011a,b), plant physiology (Leiss et al.,
2009), microbial biochemistry (Vinayavekhin and Saghatelian,
2009), and mode of action of drugs (Allen et al., 2004). However,
some important methodological concerns remain to be addressed.
For instance, although NMR gives unique structural information
regarding metabolites, it suffers from limitations in chemical
resolution and sensitivity (Schultz et al., 2013). Given that the
intensity and sensitivity of magnetic resonance signals depend on
the strength of the magnetic ﬁeld, the NMR technique is
continually being improved to include more powerful magnets
(Pourmodheji et al., 2016; Powers, 2009). In particular, recent
advances in the next generation of high-throughput NMR
spectrometers using complementary metal oxide semiconductors,
consisting of a series of high-sensitivity micro-coils integrated
with interfacing radio-frequency circuits on the same chip,
promises to enhance the sensitivity of the technique while also
ensuring that a large number of experiments can be run
simultaneously in one unit (Pourmodheji et al., 2016). In addition,
NMR evaluation of plant extracts has the challenge of extensive
resonance overlap, which could obstruct the quantiﬁcation and
identiﬁcation of metabolites. To overcome this challenge, several
NMR studies use an enrichment or fractionation step (Simmler
et al., 2014).
In comparison, the LC–MS method provides a good sensitivity
and selectivity, allowing for the detection and quantiﬁcation of less
concentrated (trace) metabolites (Sumner et al., 2003). LC–MS is
well suited for analyzing non-volatile, thermally sensitive, and
non-polar compounds which otherwise would require derivatiza-
tion prior to other MS approaches. The overall aim of metabolomics
approaches is to determine as many metabolites as possible
responsive to a given condition or a set of conditions (Fan and Lane,
2016). This indicates that the metabolomics approaches provide an
opportunity to observe several altered metabolites which may be
known (and are present in databases) or unknown (Schultz et al.,
2013). Importantly, due to sheer diversity of plant metabolites,
most databases do not provide complete coverage of metabolites.
However, if the correct structures of the metabolites are notpresent in a database, their accurate identiﬁcation may be
challenging. This notwithstanding, when coupled to a high
resolution MS, such as an Orbitrap (Kamleh et al., 2008) or time
of ﬂight (Lu et al., 2008) instrument, high mass accuracy can be
obtained for metabolite identiﬁcation (Schultz et al., 2013).
Although the high mass accuracy signiﬁcantly decreases the
potential molecular formulas corresponding to an individual
metabolic peak, problems do arise with this approach as there
may be several molecular formulas appropriate for the accurate
mass data and several potential isomers for each given molecular
formula (Schultz et al., 2013). Therefore, a fragmentation mecha-
nism is usually required to provide some structural information.
Matching the fragmentation and accurate mass data with standard
MS/MS spectra in the METLIN (https://metlin.scripps.edu/) data-
base, for instance, may give a more convincing metabolite
identiﬁcation than using accurate mass data alone (Schultz
et al., 2013). In addition, accurate fragmentation patterns and
mass determination may be obtained by a combination of standard
MS/MS with electrospray ionization (ESI), which may allow de novo
metabolite structure determination. For instance, ESI–MS/MS has
been used with reverse-phased high performance liquid chroma-
tography to isolate and identify proanthocyaninidins in Saskatoon
berries (Amelanchier alnifolia) (Hellström et al., 2007). Moreover,
the LC–MS approach has been used to detect and accurately
identify a wide array of semi-polar phytochemical compounds. For
example, it has been used to examine the anti-inﬂammatory
activity of lipophilic stinging nettle extracts (Johnson et al., 2013)
and lipophilic leaf extracts of Staphylea L. species (Lacikova et al.,
2009). In identifying unknown spectral features in NMR studies,
multidimensional NMR would be essential and it would be
important to include heteronuclear NMR methods based on 15N
or 31P nuclei, rather than 13C (Fan and Lane, 2016). While the
combination of chemical shift information and heteronuclear
scalar coupling may be sufﬁcient in identifying a given compound
by comparison with databases or comparison with a compiled list
of chemical shifts with different functional groups, the functional
groups of such compounds may not be clear unless one carries out
additional experiments. Such additional experiments could take
the form of pH titrations to conﬁrm the presence or otherwise of
carboxyl or amino functional groups (Fan and Lane, 2016).
In Africa, metabolomics and metabonomics approaches are
currently being employed in research on diseases such as HIV/AIDS
(Sitole et al., 2013), schistosomiasis (Balog et al., 2011), and
tuberculosis (Mahapatra et al., 2014; Olivier and Loots, 2012), as
well as in the study of antifungal agents (Tugizimana et al., 2014),
soya-milk (Ogegbo et al., 2012) and anti-HIV chemical entities
(Heyman et al., 2015). However, little attention has been paid to the
application of metabolomics and metabonomics approaches in the
study of TAMs.
4. Metabolomics for advancing TAMs-based research on
preventive treatment and personalized medicine in Africa
Metabolomics in combination with pharmacology provide
robust means for the discovery of novel active compounds and
may as well be useful in proving the occurrence of synergy and
prodrugs (Verpoorte et al., 2009). Given that metabolomics
provides some of the most advanced approaches to molecular
system readout and offers excellent technological platforms for
discovering biomarkers associated with healthy and diseased
states, it could play crucial roles in the design of individualized
interventions and personalized health monitoring programs
(Wang et al., 2011a,b). In practice, personalized medicine involves
a customized medical care tailored towards each individual
patient’s unique condition. Thus implementing a systems ap-
proach would make signiﬁcant contributions in disease
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system-wide molecular perturbations resulting from disease
processes (van der Greef et al., 2006). Currently, there is a growing
interest in personalized medicine as well as preventive treatment
options (Wang et al., 2011a,b). The concepts pertaining to
personalized medicine and preventive treatment have three main
foci: (a) disease control  stressing on regimen and disease
prevention (b) early diagnosis, treatment and control of the
evolution of disease, and (c) prognosis and prevention of disease
recurrence (Wang et al., 2011a,b). Premedical intervention before
disease is a key aspect of TAMs usage in tackling health challenges
in Africa. Scientiﬁc interpretations of some successes of various
preventive treatments involving traditional medicines in China
and elsewhere suggest that disease prevention; especially those
targeted towards individual conditions should surpass medical
intervention in humans (Liang and Yin, 2010). Metabolomics holds
the potential of enabling the identiﬁcation of predictive biomark-
ers that can signal the onset of speciﬁc diseases and as well deﬁne
TAMs that can be useful in early interventions. Indeed, some
studies have already demonstrated that early-intervention metab-
olomic approaches may provide deeper insights into disease-
preventive mechanisms in clinical trials (Bast, 2004; Martin et al.,
2009; Winnike et al., 2010). At present, it is widely believed that
elimination of cancer and related diseases will likely be dependent
on both individualized treatment and earlier detection as well as
prevention of malignancies (Bast, 2004). Metabolomics-based
investigations of TAMs, on the one hand, and traditional medicines
in general, may be crucial in combatting cancer and several other
diseases confronting mankind. Already, evidence suggests that
some TAMs possess anticancer and anti-inﬂammatory properties
(Akindele et al., 2015; Dzoyem and Eloff, 2015). Using metabolomic
approaches to expand and conﬁrm ﬁndings from such initial
studies would be essential in the development of novel therapeu-
tics against cancer and several other diseases in Africa and
elsewhere. The integration of metabolomics approaches in the
study of TAMs by African scientists may contribute immensely to
the advancement of research, early diagnosis, preventive treat-
ment and personalized medicine on the continent.
5. Using metabolomics to ensure quality control of TAMs
Standardization and quality control assurance of herbal
products are essential in the protection of the integrity of the
products and in meeting pharmaceutical quality. Standardization
and quality control are also essential to ensure the reproducibility
of the effect of active ingredients (Heyman and Meyer, 2012). The
main parameters required for certifying the quality and safety of
herbal products may include, but may not be limited to: (a)
deﬁnitive identiﬁcation and taxonomic classiﬁcation of plants e.g.
through DNA bar coding and ﬁngerprinting, (b) identiﬁcation of
the main bioactive constituents, (c) determination of the structure
of the major constituents, (d) standardization of single extract or
multi-compound extract ﬁngerprints, and (e) harmonization of
standardization criteria under the relevant state and international
authorization bodies (Heyman and Meyer, 2012; Slater et al., 2015).
From the criteria it becomes evident that standardization of herbal
products could be quite difﬁcult to achieve given the numerous
factors that could inﬂuence the standardization process. Thus, it
becomes important to optimize all aspects of the process from
plant cultivation, harvesting, sample preparation to analysis.
Spectroscopic and chromatographic techniques could be adopted
to facilitate the quality control process. Using these high-
throughput techniques it becomes possible to generate a
standardized metabolic ﬁngerprint of any given herbal product
(Sheridan et al., 2012). Metabolic proﬁling methods could then be
used to identify the multiple constituents of the herbal productmaking up the metabolic ﬁngerprint. These techniques, may
therefore aid in obtaining relatively accurate, reliable and
reproducible assessment of herbal products for clinical use
(Sheridan et al., 2012).
6. Working at the metabolite level: beneﬁts and limitations
6.1. Beneﬁts
Metabolite measurements are crucial given their importance as
components of biochemical pathways, the signiﬁcance of some
metabolites in human diet and their potential role as biomarkers
for a wide range of biological conditions (Hall, 2006). Improvement
in our ability to characterize changes in metabolite contents from
seemingly unconnected pathways is facilitating our understanding
of how cells prioritize and partition important nutrients in
different conditions. Several studies are implicating metabolites
in mediating gene expression (Baier et al., 2004; Lancien and
Roberts, 2006), and demonstrating their key role in determining
responses to perceived stress and developmental cues (Panicot
et al., 2002). Moreover, there are suggestions from yeast-based
studies indicating that metabolites can also inﬂuence protein
stability and act as mobile cellular and intracellular signals
(Fafournoux et al., 2000). There is also little doubt that the
phenotype of biological systems are largely determined by their
metabolic composition (Fernie, 2007), providing a strong reason to
invest time, funds, and research efforts into furthering our
understanding of how this phenomenon is mediated. The fact
that metabolomic entities operate at a level directly impacting
biological function is the key reason necessitating its application in
the study of TAMs for establishing the disease-modifying actions of
these products.
6.2. Limitations
Set against the numerous advantages of metabolomics is the
fact that measurement of metabolites could be difﬁcult, mostly due
to their dynamic behavior as well as the diversity of their chemical
nature (Stitt and Fernie, 2003). The chemical diversity of
metabolites is much more than that of nucleic acids and proteins
given the enormous diversity in their structure. This structural
diversity therefore confers a broad range of chemical properties,
which may be a problem when ﬁnding suitable extraction buffers.
This diversity also implies that there is no single extraction
procedure that does not cause substantial loss of some cellular
metabolites (Fernie, 2007). In addition, there is no single
metabolomics platform existing currently that can measure all
metabolites (Fernie, 2007). Another major disadvantage in the
study of TAMs at the metabolite level has to with the greater
metabolic diversity in plants. In this regard, while the genome of
Arabidopsis has approximately the same number of genes as
humans, the metabolic diversity in the former is far greater than
the latter (De Luca and St Pierre, 2000). The plant kingdom
contains over 200,000 metabolites (De Luca and St Pierre, 2000)
with individual species having about 15,000 metabolites (Hart-
mann et al., 2005). Given that currently existing metabolite
proﬁling methods cover only a fraction of the full metabolite
complement of the cell, this represents a key limitation.
7. Integrating metabolomics approaches into TAMs research:
challenges and solutions
While metabolomic platforms could play crucial roles in the
advancement of research on TAMs, their adoption may be hindered
by a number of factors. Among these factors are limited resources
and research funding. The cost of metabolomic technologies such
E. Quansah, T.K. Karikari / Phytochemistry Letters 17 (2016) 270–277 275as NMR and mass spectrometers can be a critical barrier to the
application of metabolomics approaches in research and clinical
use of TAMs in Africa. However, African universities and hospitals
could beneﬁt from organizations such as Adéquation (http://
adequationgermany.embl.de/), Seeding Labs (http://seedinglabs.
org/), and TReND in Africa (http://trendinafrica.org/), which supply
second-hand medical and laboratory equipment in good condition
(Quansah and Karikari, 2015a,b). In addition, African governments
need to commit to supporting local scientiﬁc research with at least
1% of each nation’s gross domestic product as indicated by the
African Union (Quansah and Karikari, 2015a).
Another potential impediment to the use of metabolomics
approaches in TAMs-based research may be the lack of well-
resourced scientists with metabolomics know-how. Metabolomics
research remains relatively new to most research and clinical
institutions in Africa. As such, many institutions on the continent
may lack appropriately trained scientists. However, national
training programs on metabolomics could be organized in various
African countries to train a few local researchers and clinicians,
who could then lead metabolomics research in their respective
institutions. Moreover, training programs organized under the
H3Africa (Human Heredity and Health in Africa; http://www.
h3africa.org/) initiative and other similar initiatives could be
expanded to accommodate metabolomics research approaches.
Addressing these challenges would be crucial in the adoption of
metabolomics to improve TAMs research on the continent.
8. Conclusion
The steady growth of the global market for traditional
medicines suggest that increased research utilizing modern
research technologies may be essential to improve our under-
standing of the composition, efﬁcacy, safety and tolerability of
traditional African medicines, if they are to have a more global
appeal. Metabolomics platforms offer an excellent means of
determining the composition and holistic effect of TAMs on
biological systems, therefore representing a means for Africa to
extend the clinical use of TAMs and for the discovery of novel drugs
that may be speciﬁc for local populations.
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